INVENTRONICS LTD (IVX.CA) Stock Fundamental Analysis
TSX-V:IVX - CA4612082095 - Common Stock
0.8 CAD
0 (0%)
We assign a fundamental rating of 4 out of 10 to IVX. IVX was compared to 4 industry peers in the Building Products industry. IVX has an average financial health and profitability rating. IVX has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
IVX had positive earnings in the past year.
IVX had a positive operating cash flow in the past year.
Of the past 5 years IVX 4 years were profitable.
IVX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of IVX (1.84%) is worse than 75.00% of its industry peers.
Looking at the Return On Equity, with a value of 4.61%, IVX is doing worse than 75.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.94%, IVX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IVX is significantly above the industry average of 3.94%.
The 3 year average ROIC (16.93%) for IVX is well above the current ROIC(3.94%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 4.61% | ||
| ROIC | 3.94% |
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
1.3 Margins
IVX has a worse Profit Margin (1.55%) than 75.00% of its industry peers.
IVX has a better Operating Margin (3.92%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of IVX has declined.
With a Gross Margin value of 17.94%, IVX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
IVX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.92% | ||
| PM (TTM) | 1.55% | ||
| GM | 17.94% |
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
2. Health
2.1 Basic Checks
IVX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for IVX remains at a similar level compared to 1 year ago.
IVX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IVX has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.47 indicates that IVX is not a great score, but indicates only limited risk for bankruptcy at the moment.
IVX has a Altman-Z score of 2.47. This is comparable to the rest of the industry: IVX outperforms 50.00% of its industry peers.
IVX has a debt to FCF ratio of 4.28. This is a neutral value as IVX would need 4.28 years to pay back of all of its debts.
IVX has a Debt to FCF ratio of 4.28. This is amongst the best in the industry. IVX outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that IVX is somewhat dependend on debt financing.
IVX has a worse Debt to Equity ratio (0.90) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | 4.28 | ||
| Altman-Z | 2.47 |
ROIC/WACC0.44
WACC9.02%
2.3 Liquidity
A Current Ratio of 2.34 indicates that IVX has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.34, IVX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
IVX has a Quick Ratio of 1.54. This is a normal value and indicates that IVX is financially healthy and should not expect problems in meeting its short term obligations.
IVX has a Quick ratio of 1.54. This is amongst the best in the industry. IVX outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.34 | ||
| Quick Ratio | 1.54 |
3. Growth
3.1 Past
IVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 113.76%, which is quite impressive.
IVX shows a small growth in Revenue. In the last year, the Revenue has grown by 4.99%.
The Revenue has been growing slightly by 2.21% on average over the past years.
EPS 1Y (TTM)113.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2250%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%69.48%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 40.00, the valuation of IVX can be described as expensive.
Based on the Price/Earnings ratio, IVX is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.13. IVX is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IVX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
IVX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IVX is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.97 | ||
| EV/EBITDA | 12 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
IVX has a Yearly Dividend Yield of 23.33%, which is a nice return.
Compared to an average industry Dividend Yield of 23.33, IVX pays a better dividend. On top of this IVX pays more dividend than 100.00% of the companies listed in the same industry.
IVX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 23.33% |
5.2 History
IVX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IVX pays out 430.97% of its income as dividend. This is not a sustainable payout ratio.
DP430.97%
EPS Next 2YN/A
EPS Next 3YN/A
TSX-V:IVX (8/29/2025, 7:00:00 PM)
0.8
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.93%
Ins Owner ChangeN/A
Market Cap3.90M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 23.33% |
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP430.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40 | ||
| Fwd PE | N/A | ||
| P/S | 0.53 | ||
| P/FCF | 6.97 | ||
| P/OCF | 5.32 | ||
| P/B | 1.59 | ||
| P/tB | 1.59 | ||
| EV/EBITDA | 12 |
EPS(TTM)0.02
EY2.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY14.35%
OCF(TTM)0.15
OCFY18.79%
SpS1.5
BVpS0.5
TBVpS0.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 4.61% | ||
| ROCE | 5.84% | ||
| ROIC | 3.94% | ||
| ROICexc | 4.34% | ||
| ROICexgc | 4.34% | ||
| OM | 3.92% | ||
| PM (TTM) | 1.55% | ||
| GM | 17.94% | ||
| FCFM | 7.65% |
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
ROICexc(3y)18.71%
ROICexc(5y)18%
ROICexgc(3y)18.71%
ROICexgc(5y)18%
ROCE(3y)25.1%
ROCE(5y)24.63%
ROICexcg growth 3Y-68.88%
ROICexcg growth 5Y-39.12%
ROICexc growth 3Y-68.88%
ROICexc growth 5Y-39.12%
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
F-Score7
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | 4.28 | ||
| Debt/EBITDA | 4.53 | ||
| Cap/Depr | 86.5% | ||
| Cap/Sales | 2.37% | ||
| Interest Coverage | 1.99 | ||
| Cash Conversion | 150.62% | ||
| Profit Quality | 494.69% | ||
| Current Ratio | 2.34 | ||
| Quick Ratio | 1.54 | ||
| Altman-Z | 2.47 |
F-Score7
WACC9.02%
ROIC/WACC0.44
Cap/Depr(3y)281.39%
Cap/Depr(5y)239.45%
Cap/Sales(3y)5.39%
Cap/Sales(5y)4.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)113.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2250%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.99%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%69.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.55%
EBIT growth 3Y-69.33%
EBIT growth 5Y-34.39%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.84%
FCF growth 3Y-16.33%
FCF growth 5Y11.05%
OCF growth 1Y-74.33%
OCF growth 3Y-11.65%
OCF growth 5Y14.04%